Pacira Pharmaceuticals, Inc.
San Diego, CA, United States
This page shows every FDA and USDA recall linked to Pacira Pharmaceuticals, Inc.. Each entry includes the product involved, when the recall happened, and how serious it was. If a company has had multiple recalls over the years, you can see the full history here in one place — including whether any were Class I, which is the most serious type.
4
Total Recalls
2012
First Recall
2024
Most Recent
Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactur...
Jul 3, 2024
· Drug
Class II
Active
Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, R...
Jun 19, 2024
· Drug
Class II
Active
EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx on...
Dec 11, 2019
· Drug
Class II
Terminated
EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVES...
Mar 6, 2013
· Drug
Class II
Terminated